Literature DB >> 12900288

To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.

Tsung-Huai Kuo1, Feng-Yu Liu, Cheng-Yen Chuang, Hurng-Sheng Wu, Jhi-Joung Wang, Albert Kao.   

Abstract

Our preliminary studies found technetium-99m tetrofosmin (Tc- TF) chest imaging was related to Pgp or MRP1 expression and successfully predict chemotherapy response and in SCLC in human. However, there was no published literature to study relationship of Tc-TF chest images and LRP expression in SCLC patients. Therefore, the aim of this study was to investigate the relationships among Tc- TF accumulation in untreated small cell lung cancer (SCLC), the expression of P-glycoprotein (Pgp), multidrug resistance related protein-1 (MRP1), and lung resistance-related protein (LRP), as well as the response to chemotherapy in patients with untreated SCLC. Thirty patients with SCLC were studied with chest images 15 to 30 minutes after intravenous injection of Tc-TF before chemotherapeutic induction. Tumor-to-background (T/B) ratios were obtained on the static and plantar Tc-TF chest images. The response to chemotherapy was evaluated upon completion of chemotherapy by clinical and radiological methods. These patients were separated into 15 patients with good response and 15 patients with poor response. No significant differences of prognostic factors (Karnofsky performance status, tumor size, or tumor stage) were found between the patients with good and poor responses. Immunohistochemical analyses were performed on multiple nonconsecutive sections of biopsy specimens to detect Pgp, MRP1, and LRP expression. The difference in T/B ratios on the Tc-TF chest images of the patients with good versus poor response was significant. The differences in T/B ratios of the patients with positive versus negative Pgp expression and with positive versus negative MRP1 expression were significant. The difference in T/B ratios of the patients with positive versus negative LRP expression was not significant. We concluded that Tc-TF chest images could accurately predict chemotherapy response of patients with SCLC. In addition, The Tc-TF tumor uptake was related to Pgp or MRP1 but not LPR expression in SCLC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900288     DOI: 10.1016/s0969-8051(03)00058-1

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  7 in total

1.  miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1.

Authors:  Huanxin Liu; Xiaoxia Wu; Jie Huang; Juan Peng; Linlang Guo
Journal:  Int J Exp Pathol       Date:  2015-06-24       Impact factor: 1.925

Review 2.  Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).

Authors:  Eva Bakos; László Homolya
Journal:  Pflugers Arch       Date:  2006-12-23       Impact factor: 3.657

3.  Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro.

Authors:  Lilia Peigñan; Wallys Garrido; Rodrigo Segura; Rómulo Melo; David Rojas; Juan Guillermo Cárcamo; Rody San Martín; Claudia Quezada
Journal:  Neurochem Res       Date:  2011-05-05       Impact factor: 3.996

4.  Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer.

Authors:  J-J Yeh; N-Y Hsu; W-H Hsu; C-H Tsai; C-C Lin; J-A Liang
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

Review 5.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

Review 6.  MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

Review 7.  Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma.

Authors:  Anna Alisi; William C Cho; Franco Locatelli; Doriana Fruci
Journal:  Int J Mol Sci       Date:  2013-12-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.